135. Ketamine Treatment in Major Depression: Predictive Power of Heart Rate

      Ketamine has been shown to be effective in the treatment of therapy resistant episodes of major depressive disorder (MDD). Although some studies have evaluated possible clinical and anamnestic predictors of outcome following ketamine infusion there is a lack of objective biological markers. Therefore, this study aimed to analyze the predictive power of heart rate (HR) and heart rate variability (HRV) for ketamine treatment in major depressive disorder.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect